Compare BioNano Genomics Inc (BNGO) vs Invesco Galaxy Bitcoin ETF (BTCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Invesco Galaxy Bitcoin ETF — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.20M), while Invesco Galaxy Bitcoin ETF trades at $65.08. Which is the better fit depends on your goals.
| BNGO | BTCO | |
|---|---|---|
Market Cap | $13.20M | — |
Sector | Health | Crypto-linked |
52-Week High | $4.92 | $125.14 |
52-Week Low | $1.09 | $58.40 |
Enterprise Value | $15.81M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
BTCO trades at $61.86, down 2.67% today amid mixed technical signals with a bullish overall trend but bearish moving averages. The stock faces resistance near $64-65 while finding support around $62-63. Financial ratios remain unavailable in current data, requiring deeper fundamental analysis.
The stock shows technical resilience despite recent selling pressure, with key support levels holding. Investment appeal depends on upcoming earnings clarity and institutional positioning. Primary risks include market volatility and competitive pressures in its sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Invesco Galaxy Bitcoin ETF
BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.
Read more on BTCO →
